In our weekly Trends that Matter series, we provide engaging infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is digital health. As digital technology continues to evolve, pharma companies must change their communication tactics to engage with patient communities.
In the past, many pharma companies have shied away from digital marketing due to concerns over healthcare regulations. However, in the past year, the FDA’s Center for Devices and Radiological Health (CDRH) has expressed interest in advancing digital health initiatives. The FDA states:
"The use of technologies such as smart phones, social networks and internet applications is not only changing the way we communicate, but is also providing innovative ways for us to monitor our health and well-being and giving us greater access to information. Together these advancements are leading to a convergence of people, information, technology and connectivity to improve health care and health outcomes."
In addition, the FDA recently announced plans to create a new Digital Health Unit within the CDRH branch. With these industry advancements in mind, many healthcare experts report that it is a good time to invest in the areas of mobile health, health IT, wearable devices, telemedicine, and personalized medicine.
To learn more about this topic, read the article "Pharma Raises Stakes in Digital Health" written by Michelle Maskaly, a Senior Editor at the Pharmaceutical Executive.